Latest News and Press Releases

McHenry, IL, May 05, 2022 (GLOBE NEWSWIRE) -- Medela, the most trusted breast pump brand*, has announced a partnership with Expectful, a holistic maternal health platform for fertility, pregnancy,...

在临床三期AirFLO试验中，爱司韦™与安慰剂相比显著降低症状评分（p=0.002）及病毒载量（p=0.006），达到试验主要终点和关键次要终点 RSV感染是五岁以下儿童因病毒感染而住院及死亡的首要因素爱司韦™是全球首个成功在儿童患者人群中完成关键性三期临床研究的RSV抗病毒药物爱司韦™计划于2022年年中向中国监管机构提交新药上市申请 上海, April 07, 2022 (GLOBE...

在臨床三期AirFLO試驗中，愛司韋™與安慰劑相比顯著降低症狀評分（p=0.002）及病毒載量（p=0.006），達到試驗主要終點和關鍵次要終點 RSV感染是五歲以下兒童因病毒感染而住院及死亡的首要因素愛司韋™是全球首個成功在兒童患者人群中完成關鍵性三期臨床研究的RSV抗病毒藥物愛司韋™計畫於2022年年中向中國監管機構提交新藥上市申請 上海, April 07, 2022 ...

Phase 3 AirFLO study with ziresovir met primary and key secondary endpoints of significant reduction of sign-and-symptom score (p=0.002) and viral load (p=0.006) respectively, compared with...

VANCOUVER, British Columbia , Jan. 05, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — PlantX Life Inc. (the “Company” or “PlantX”) (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is pleased to announce...

ATLANTA, GA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Gone are the days of wondering, “What are my child’s developmental milestones?” and “How do I keep my child safe indoors?.” Starting today, parents...

Bedford, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- SynBioBeta’s (SBB) Synthetic Biology Global Conference awarded Conagen the “Best Product of the Year” for its human lactoferrin and non-GMO human...

BEVERLY HILLS, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Mounting scientific evidence is showing that chemicals and toxins used in foods and medicines for preserving, flavoring and packaging may...

Den 30 augusti 2018 meddelade Infant Bacterial Therapeutics AB (publ) ("IBT" eller "Bolaget") att Nasdaq Stockholms bolagskommittée godkände ansökan om upptagande till handel av Bolagets aktier i...

On August 30, 2018, Infant Bacterial Therapeutics AB (publ) (”IBT” or the ”Company”) announced that Nasdaq Stockholm’s Listing Committee had approved the admission of the Company’s shares of series B...